CTOIJ HomeEditorial May 27, 2024
Challenges with Bruton’s Tyrosine Kinase Inhibitors Treatment
Nahla A M Hamed*
Cancer therapy & Oncology International Journal is dedicated to publish the contributions on all aspects of experimental and clinical cancer research. CTOIJ is a multidisciplinary, open access, peer reviewed journal accepts Research, Review Articles, Short Communications, Mini- Review, Case Reports, Opinions, Letter to Editors etc., Authors are requested to submit complete unpublished and original works, including but not limited to the following fields: cancer biology, cancer science and therapeutics, cancer nanotechnology, cancer detection and prevention, radiology, radiation oncology, radiation therapy, medical and clinical oncology. CTOIJ providing a platform for researchers, scholars, clinicians and academicians to collaborate and share knowledge.
Nahla A M Hamed*
Peter A Owonaro*, Chima ifeanyi E, Joabuchi Ernest Chinwendu, and Ismail A Suleiman
Selcuk Demiral*, Ferrat Dincoglan, Omer Sager and Murat Beyzadeoglu
Omer Sager*, Ferrat Dincoglan, Selcuk Demiral and Murat Beyzadeoglu
Bora Uysal* and Hakan Gamsiz
Bora Uysal* and Hakan Gamsiz
Open Access by Juniper Publishers is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at www.juniperpublishers.com. 
| Above IE 7.0 version | Privacy Policy
